4//SEC Filing
HANSEN JOHN DAVID 4
Accession 0001415889-17-001611
CIK 0001109196other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:20 AM ET
Size
5.9 KB
Accession
0001415889-17-001611
Insider Transaction Report
Form 4
HANSEN JOHN DAVID
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Unit
2017-10-02+551,156→ 551,156 total→ Common Stock (551,156 underlying)
Footnotes (1)
- [F1]Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186123
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 6:20 AM ET
- Size
- 5.9 KB